• Hey Guest,

    We wanted to share a quick update with the community.

    Our public expense ledger is now live, allowing anyone to see how donations are used to support the ongoing operation of the site.

    👉 View the ledger here

    Over the past year, increased regulatory pressure in multiple regions like UK OFCOM and Australia's eSafety has led to higher operational costs, including infrastructure, security, and the need to work with more specialized service providers to keep the site online and stable.

    If you value the community and would like to help support its continued operation, donations are greatly appreciated. If you wish to donate via Bank Transfer or other options, please open a ticket.

    Donate via cryptocurrency:

    Bitcoin (BTC):
    Ethereum (ETH):
    Monero (XMR):
geepeedee

geepeedee

no future
Feb 24, 2026
149
how much quetiapine should i use as a replacement for meto in my SN protocol?
 
absolutethistime

absolutethistime

shinigami
Feb 20, 2026
33
I would be very careful trying to replace it with Quetiapine.

Metoclopramide
Core action:
  • Strong D2 receptor antagonist (especially in the chemoreceptor trigger zone)
  • Mild 5-HT3 antagonist
  • 5-HT4 agonist (prokinetic → gut motility)
Dose vs binding (simplified reality)
  • Low dose (~5–10 mg):
    • Already substantial D2 blockade (this drug doesn't "ease into it")
    • Enough for anti-nausea effects
  • Moderate dose (~10–20 mg):
    • Near-maximal central D2 occupancy
    • Increased risk of extrapyramidal symptoms (EPS)
  • High dose / repeated dosing:
    • Doesn't meaningfully increase D2 selectivity—just increases side effects
    • Acute dystonia, akathisia, parkinsonism risk climbs fast
Quetiapine
Core action (very dose-dependent):
  • H1 (histamine) blockade → sedation
  • 5-HT2A antagonism
  • D2 antagonism (weak + transient)
  • α1 blockade → orthostasis

Dose-dependent binding profile

  • Very low dose (25–50 mg):
    • Dominant: H1 blockade
    • Result: heavy sedation, basically an antihistamine in disguise
    • Minimal D2 occupancy
  • Low–moderate (100–300 mg):
    • Strong 5-HT2A antagonism
    • Some D2 engagement, but still relatively weak
    • Used for mood stabilization / bipolar depression
  • High dose (300–800 mg):
    • Meaningful D2 occupancy (~40–60%), but still lower than typical antipsychotics
    • Antipsychotic effects emerge
    • Still less EPS than drugs with tighter D2 binding
 

Similar threads

S
Replies
0
Views
199
Suicide Discussion
StoneCactus
S
HopeIess
Replies
4
Views
147
Suicide Discussion
uselessmanz
U
meowzers3276
Replies
10
Views
281
Suicide Discussion
meowzers3276
meowzers3276
AFoxMissingAMagpie
Replies
1
Views
117
Suicide Discussion
FuneralCry
FuneralCry